Retrospective Observational Analysis of Tocilizumab Outcomes in COVID-19 Patients at a Tertiary Care Hospital

• Κύριοι συγγραφείς: Vrushali Avinash Aringale (Συγγραφέας), Bharti Daswani (Συγγραφέας), Madeline Fernandes (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Research Center for Rational Use of Drugs (RCRUD), 2024-04-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Tocilizumab (TCZ), a monoclonal antibody against interleukin-6 (IL-6), was recommended for treatment of Covid-19 patients with a risk of cytokine storm but showed variable effect on outcome. The aim was to assess the association of outcome following tocilizumab administration with variou...